AgNovos Bioscience
Rockville, US · Founded 2022 · Delaware corporation
Founders & leadership
JF
Jason FoleyNamed on SEC filing
JP
James PilachowskiNamed on SEC filing
DS
David StillerNamed on SEC filing
RS
Robert StillerNamed on SEC filing
EZ
Ellen ZaneNamed on SEC filing
NV
Nick ValerianiNamed on SEC filing
SK
Stephanie KladakisNamed on SEC filing
JS
James ShimpNamed on SEC filing
FD
Falk DukatzNamed on SEC filing
MS
Michael SchmertzlerNamed on SEC filing
JG
James G. HoweNamed on SEC filing
JB
James BarryNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$44.8M disclosed across 2 rounds · 2023
▶$13.4MraisedMar 2024 · 8 investors · Other Health CareRule 506(b)
▶$13.4MraisedMar 2024 · 8 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- James T. HoweExecutive Officer, Director
- James ShimpExecutive Officer
- Dawn SvoronosDirector
- James PilachowskiExecutive Officer
- Jason FoleyExecutive Officer
- Stephanie KladakisExecutive Officer
- James BarryDirector
- Falk DukatzExecutive Officer
- Jarrett WaldnerExecutive Officer
- Adam LoweExecutive Officer
- James G. HoweExecutive Officer, Director
- Michael SchmertzlerDirector
- Robert StillerDirector
- David StillerDirector
- Nick ValerianiDirector
- Bill BeasleyExecutive Officer
- Chris GegeylsExecutive Officer
- Ellen ZaneDirector
- Offering amount
- $13.4M
- Amount sold
- $13.4M
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$31.5MraisedJun 2023 · 4 investors · Other Health CareRule 506(b)
▶$31.5MraisedJun 2023 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jason FoleyExecutive Officer
- James PilachowskiExecutive Officer
- David StillerDirector
- Robert StillerDirector
- Ellen ZaneDirector
- Nick ValerianiDirector
- Stephanie KladakisExecutive Officer
- James ShimpExecutive Officer
- Falk DukatzExecutive Officer
- Michael SchmertzlerDirector
- James G. HoweExecutive Officer, Director
- James BarryDirector
- Jarrett WaldnerExecutive Officer
- Chris GegeylsExecutive Officer
- James T. HoweExecutive Officer, Director
- Adam LoweExecutive Officer
- Dawn SvoronosDirector
- Offering amount
- $60M
- Amount sold
- $31.5M
- Proceeds to insiders
- $1.8M
- First sale
- May 2023
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has AgNovos Bioscience raised?
- AgNovos Bioscience has disclosed $44.8M raised across 2 rounds.
- Where is AgNovos Bioscience headquartered?
- AgNovos Bioscience is headquartered in Rockville, US.